Authority: Supreme Court of India (Civil Appellate Jurisdiction)
Order Date: 05 October 2026
Case Overview
- Appellant: D. Aravindakshan Kovilakom
- Respondent: M/s. Agastya Biopharm India Ltd.
- Appeal against NCLAT Chennai judgment dated 22 April 2026 in Company Appeal (AT)(CH) No.48/2026.
- Counsel for appellant: Mr. Saurabh Bhargavan, Adv.; Mr. Nikhil S. Nair, Adv.; Ms. Chinju Saurabh, Adv.; Mr. Nishad L., S‑3815, AOR.
- Counsel for respondent: not listed in the record.
- Bench: Hon'ble Mr. Justice Sanjay Kumar and Hon'ble Mr. Justice Sanjeev Sachdeva.
Observations & Reasoning
- The Court found no grounds to interfere with the impugned judgment of the National Company Law Appellate Tribunal dated 22 April 2026.
- Accordingly, the appeal is dismissed.
- The Court ordered that any pending application(s), if any, stand disposed of.
Final Outcome
- The Supreme Court order dismisses the appeal, leaving the NCLAT decision of 22 April 2026 effective and binding.
- All pending applications related to the appeal are closed.
Additional Formalities
- Order signed by Justices Sanjay Kumar and Sanjeev Sachdeva.
- Deputy Registrar Court Master (NSH) Deepak Guglani and Preeti Saxena recorded the signed order on the file.
Topics: Company Law, Supreme Court Decision